Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 42Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Clinigen Group

02 1ORPHAN EUROPE SARL

03 3Recordati Rare Diseases

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Hemin

Brand Name : Normosang 25mg/ml (10 ml ampoules)

Dosage Form : INJ

Dosage Strength : 25mg/ml

Packaging : 4X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Hemin

Brand Name : Normosang

Dosage Form : Hemin 250Mg 10Ml 4 Units Parenteral Use

Dosage Strength : 4 ampoules EV 250 mg 10 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Hemin

Brand Name : Normosang

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date : 16/07/1999

Application Number : 19990716000037

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

HEMIN

Brand Name : PANHEMATIN

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 268MG/VIAL

Packaging :

Approval Date :

Application Number : 2478765

Regulatory Info : Schedule D

Registration Country : Canada

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Hemina

Brand Name : Normosang

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 25MG

Packaging :

Approval Date : 2000-06-13

Application Number : 63116

Regulatory Info : Authorized

Registration Country : Spain

blank